StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Motilal Oswal

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byMotilal OswalHorizon: NA (inferred 1 year)31 Jan 2026via Institutional / Brokerage Research

Entry₹1,640Inferred
Target₹1,940
Total upside +18.29% (call closed)
Stop lossNot given
Exit₹1,9409 Jul 2026, 12:07 pm
Target hit+18.29%0.00%upside left
Follow Motilal Oswal for new calls(62% target hit, 1108 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 15 active Long-term calls on SUNPHARMASee 211 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 9 Jul 2026
4 supporting3 neutral0 opposing
Supports the BUY call (4)

Sun Pharma has entered into an agreement to acquire 100% outstanding shares of Innovcare Lifesciences Private Limited for approximately Rs 271.2 Crores. Innovcare is engaged in marketing, distribution

BSE · Company Update·20 Jun · 3w ago

(opens in new tab)

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·28 Apr · 2mo ago

Neutral / worth noting (3)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Motilal Oswal

Every call and its outcome